IL86443A0 - Protein absorption enhancing agents - Google Patents

Protein absorption enhancing agents

Info

Publication number
IL86443A0
IL86443A0 IL86443A IL8644388A IL86443A0 IL 86443 A0 IL86443 A0 IL 86443A0 IL 86443 A IL86443 A IL 86443A IL 8644388 A IL8644388 A IL 8644388A IL 86443 A0 IL86443 A0 IL 86443A0
Authority
IL
Israel
Prior art keywords
toxic salt
enhancing agents
absorption enhancing
protein absorption
hydroxylamine
Prior art date
Application number
IL86443A
Other languages
English (en)
Original Assignee
Survival Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Survival Technology filed Critical Survival Technology
Publication of IL86443A0 publication Critical patent/IL86443A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL86443A 1987-05-28 1988-05-19 Protein absorption enhancing agents IL86443A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/054,898 US4839170A (en) 1985-10-01 1987-05-28 Protein absorption enhancing agents

Publications (1)

Publication Number Publication Date
IL86443A0 true IL86443A0 (en) 1988-11-15

Family

ID=21994232

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86443A IL86443A0 (en) 1987-05-28 1988-05-19 Protein absorption enhancing agents

Country Status (8)

Country Link
US (1) US4839170A (de)
EP (1) EP0292908B1 (de)
JP (1) JPS63297331A (de)
AT (1) ATE79550T1 (de)
AU (1) AU627125B2 (de)
CA (1) CA1335788C (de)
DE (1) DE3873825T2 (de)
IL (1) IL86443A0 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
IL267689B2 (en) 2016-12-31 2025-05-01 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
BR112020026672A2 (pt) 2018-06-27 2021-03-30 Bioxcel Therapeutics, Inc. Formulações de filme contendo dexmedetomidina e métodos para produzi-las
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents
US4658830A (en) * 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
EP0214281B1 (de) * 1985-03-06 1992-09-09 Survival Technology, Inc. Mittel zur absorptionsverbesserung von proteinen
ZA861695B (en) * 1985-03-06 1986-10-29 Survival Technology T-pa composition and method of getting into blood stream

Also Published As

Publication number Publication date
ATE79550T1 (de) 1992-09-15
EP0292908A1 (de) 1988-11-30
DE3873825T2 (de) 1993-06-24
JPS63297331A (ja) 1988-12-05
US4839170A (en) 1989-06-13
EP0292908B1 (de) 1992-08-19
CA1335788C (en) 1995-06-06
AU1616488A (en) 1988-12-01
AU627125B2 (en) 1992-08-13
DE3873825D1 (de) 1992-09-24

Similar Documents

Publication Publication Date Title
IL76119A (en) Device for initiating reperfusion treatment when heart attack symptoms are present
CS590188A2 (en) Method of erythropoietin's stabilized preparation production
EP0191056A4 (de) T-pa zusammensetzung und verfahren zu deren aufnahme in den blutstrom.
EP0318201A3 (en) Inhibition of arterial thrombotic occlusion or thromboembolism
HU896498D0 (en) Process for preparation of low volatility salts
EP0225160A3 (en) Compositions and methods for the treatment of bleeding disorders
IL91276A0 (en) Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
PT86205A (en) Process for the preparation of 3-]omega-(3,5-di-t-butil-4-hydroxyphenyl)-alkanoyl"pyrroles and their de-oxy analogs useful in therapy
IL86443A0 (en) Protein absorption enhancing agents
IL88668A0 (en) Derivatives of cyclic amino acids,a process for the preparation thereof,agents containing them,and the use thereof
GB8819607D0 (en) Novel combination
GR860329B (en) Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof
EP0305662A3 (en) Trisodium salt of 2,4,6-trisodium mercapto-s-triazine nonahydrate, and preparation method
EP0239015A3 (en) Process for producing 1-beta-d-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt and monohydrate thereof, and pharmaceutical composition containing the latter
EP0191814A4 (de) Absorptionsverbesserer für proteine.
HUT41632A (en) Process for preparing agents for the enhancement of protein absorption
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
AU1751488A (en) The use of polyvinylpyrrolidone (pvp) to reduce the turbidity of sera, sera containing pvp, and a process for the preparation thereof
EP0410652A3 (en) Improvement of excretion of potassium ion by prostanoic acid derivatives
ATE27771T1 (de) Oxytetracyclin-loesungen.
ZA882096B (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2-(bipranole)and its acid addition salts for use as active therapeutic substances
KR870700020A (ko) 단백질 흡수증가제
HU209389B (en) Method for producing tetrasodium salt of 1,4,10,13-tetraoxa-7,16-diaza-cyclooctadecane-n,n'-dimalonic acid with sodium bromide content and one for producing medical preparatives containing said compound
CS154889A1 (en) Connection for braking of spinning-in automaton's cycle drive engine

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees